{"pmid":32293832,"title":"Coronaviruses and SARS-CoV-2.","text":["Coronaviruses and SARS-CoV-2.","Coronaviruses (CoVs) cause a broad spectrum of diseases in domestic and wild animals, poultry, and rodents, ranging from mild to severe enteric, respiratory, and systemic disease, and also cause the common cold or pneumonia in humans. Seven coronavirus species are known to cause human infection, four of which, HCoV 229E, HCoV NL63, HCoV HKU1 and HCoV OC43, typically cause cold symptoms in immunocompetent individuals. The others namely SARS-CoV (severe acute respiratory syndrome coronavirus), MERS-CoV (Middle East respiratory syndrome coronavirus) were zoonotic in origin and cause severe respiratory illness and fatalities. On 31 December 2019, the existence of patients with pneumonia of an unknown etiology were reported to WHO by the national authorities in China. This virus was officially identified by the Coronavirus Study Group as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the present outbreak of a coronavirus-associated acute respiratory disease was labeled coronavirus disease 19 (COVID-19). COVID-19 was seen for the first cases in Turkey on March 10, 2020 and was number 47,029 cases and 1,006 deaths after 1 month. Infections with SARS-CoV-2 are now widespread, and as of 10 April 2020, 1,727,602 cases have been confirmed in more than 210 countries, with 105,728 deaths.","Turk J Med Sci","Hasoksuz, Mustafa","Kilic, Selcuk","Sarac, Fahriye","32293832"],"abstract":["Coronaviruses (CoVs) cause a broad spectrum of diseases in domestic and wild animals, poultry, and rodents, ranging from mild to severe enteric, respiratory, and systemic disease, and also cause the common cold or pneumonia in humans. Seven coronavirus species are known to cause human infection, four of which, HCoV 229E, HCoV NL63, HCoV HKU1 and HCoV OC43, typically cause cold symptoms in immunocompetent individuals. The others namely SARS-CoV (severe acute respiratory syndrome coronavirus), MERS-CoV (Middle East respiratory syndrome coronavirus) were zoonotic in origin and cause severe respiratory illness and fatalities. On 31 December 2019, the existence of patients with pneumonia of an unknown etiology were reported to WHO by the national authorities in China. This virus was officially identified by the Coronavirus Study Group as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the present outbreak of a coronavirus-associated acute respiratory disease was labeled coronavirus disease 19 (COVID-19). COVID-19 was seen for the first cases in Turkey on March 10, 2020 and was number 47,029 cases and 1,006 deaths after 1 month. Infections with SARS-CoV-2 are now widespread, and as of 10 April 2020, 1,727,602 cases have been confirmed in more than 210 countries, with 105,728 deaths."],"journal":"Turk J Med Sci","authors":["Hasoksuz, Mustafa","Kilic, Selcuk","Sarac, Fahriye"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293832","week":"202016|Apr 13 - Apr 19","doi":"10.3906/sag-2004-127","keywords":["Animal coronaviruses","COVID-19","History of coronaviruses","Human Coronaviruses","SARS-CoV-2"],"source":"PubMed","weight":0,"locations":["China","Turkey"],"countries":["Turkey","China"],"countries_codes":["TUR|Turkey","CHN|China"],"_version_":1664266295588159488,"score":8.233237,"similar":[{"pmid":32293743,"title":"Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated.","text":["Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated.","COVID-19 is the latest global pandemic caused by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2). There have been seven pathogenic Human Coronaviruses (HCoVs) which cause respiratory infections. Common cold coronaviruses HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1 are the four endemic HCoVs. SARS-CoV-1, MERS-CoV, SARS-CoV-2 are zoonotic emerging epidemic pathogens with significant morbidity, mortality and economic impact. The endemic HCoVs have been known to cause co-infections or can be co-detected with each other or with other respiratory viruses. In general, respiratory viral co-infections are recognized more commonly today with the use of respiratory multiplex molecular diagnostic panels. Clinicians need to be aware of co-infections among HCoVs. A high degree of suspicion in this rapidly evolving outbreak is required in order to make the diagnosis. This is vital if we are to try and contain and control the spread of the COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Chaung, Jenna","Chan, Douglas","Pada, Surinder","Tambyah, Paul A","32293743"],"abstract":["COVID-19 is the latest global pandemic caused by severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2). There have been seven pathogenic Human Coronaviruses (HCoVs) which cause respiratory infections. Common cold coronaviruses HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1 are the four endemic HCoVs. SARS-CoV-1, MERS-CoV, SARS-CoV-2 are zoonotic emerging epidemic pathogens with significant morbidity, mortality and economic impact. The endemic HCoVs have been known to cause co-infections or can be co-detected with each other or with other respiratory viruses. In general, respiratory viral co-infections are recognized more commonly today with the use of respiratory multiplex molecular diagnostic panels. Clinicians need to be aware of co-infections among HCoVs. A high degree of suspicion in this rapidly evolving outbreak is required in order to make the diagnosis. This is vital if we are to try and contain and control the spread of the COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Chaung, Jenna","Chan, Douglas","Pada, Surinder","Tambyah, Paul A"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293743","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25890","keywords":["Coronavirus","Infection","SARS coronavirus","Virus classification"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664266295592353793,"score":333.15384},{"pmid":32226286,"pmcid":"PMC7098031","title":"Zoonotic origins of human coronaviruses.","text":["Zoonotic origins of human coronaviruses.","Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. Most HCoVs originated from bats where they are non-pathogenic. The intermediate reservoir hosts of some HCoVs are also known. Identifying the animal hosts has direct implications in the prevention of human diseases. Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted.","Int J Biol Sci","Ye, Zi-Wei","Yuan, Shuofeng","Yuen, Kit-San","Fung, Sin-Yee","Chan, Chi-Ping","Jin, Dong-Yan","32226286"],"abstract":["Mutation and adaptation have driven the co-evolution of coronaviruses (CoVs) and their hosts, including human beings, for thousands of years. Before 2003, two human CoVs (HCoVs) were known to cause mild illness, such as common cold. The outbreaks of severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) have flipped the coin to reveal how devastating and life-threatening an HCoV infection could be. The emergence of SARS-CoV-2 in central China at the end of 2019 has thrusted CoVs into the spotlight again and surprised us with its high transmissibility but reduced pathogenicity compared to its sister SARS-CoV. HCoV infection is a zoonosis and understanding the zoonotic origins of HCoVs would serve us well. Most HCoVs originated from bats where they are non-pathogenic. The intermediate reservoir hosts of some HCoVs are also known. Identifying the animal hosts has direct implications in the prevention of human diseases. Investigating CoV-host interactions in animals might also derive important insight on CoV pathogenesis in humans. In this review, we present an overview of the existing knowledge about the seven HCoVs, with a focus on the history of their discovery as well as their zoonotic origins and interspecies transmission. Importantly, we compare and contrast the different HCoVs from a perspective of virus evolution and genome recombination. The current CoV disease 2019 (COVID-19) epidemic is discussed in this context. In addition, the requirements for successful host switches and the implications of virus evolution on disease severity are also highlighted."],"journal":"Int J Biol Sci","authors":["Ye, Zi-Wei","Yuan, Shuofeng","Yuen, Kit-San","Fung, Sin-Yee","Chan, Chi-Ping","Jin, Dong-Yan"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32226286","week":"202014|Mar 30 - Apr 05","doi":"10.7150/ijbs.45472","keywords":["*COVID-19","*MERS-CoV","*SARS-CoV","*SARS-CoV-2","*animal reservoir","*bats","*coronavirus"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1663352135295696896,"score":320.2639},{"pmid":32292881,"pmcid":"PMC7146059","title":"Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.","text":["Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.","Coronaviruses (CoVs) are a large family of enveloped, positive-strand RNA viruses. Four human CoVs (HCoVs), the non-severe acute respiratory syndrome (SARS)-like HCoVs (namely HCoV 229E, NL63, OC43, and HKU1), are globally endemic and account for a substantial fraction of upper respiratory tract infections. Non-SARS-like CoV can occasionally produce severe diseases in frail subjects but do not cause any major (fatal) epidemics. In contrast, SARS like CoVs (namely SARS-CoV and Middle-East respiratory syndrome coronavirus, MERS-CoV) can cause intense short-lived fatal outbreaks. The current epidemic caused by the highly contagious SARS-CoV-2 and its rapid spread globally is of major concern. There is scanty knowledge on the actual pandemic potential of this new SARS-like virus. It might be speculated that SARS-CoV-2 epidemic is grossly underdiagnosed and that the infection is silently spreading across the globe with two consequences: (i) clusters of severe infections among frail subjects could haphazardly occur linked to unrecognized index cases; (ii) the current epidemic could naturally fall into a low-level endemic phase when a significant number of subjects will have developed immunity. Understanding the role of paucisymptomatic subjects and stratifying patients according to the risk of developing severe clinical presentations is pivotal for implementing reasonable measures to contain the infection and to reduce its mortality. Whilst the future evolution of this epidemic remains unpredictable, classic public health strategies must follow rational patterns. The emergence of yet another global epidemic underscores the permanent challenges that infectious diseases pose and underscores the need for global cooperation and preparedness, even during inter-epidemic periods.","Cell Stress","Raoult, Didier","Zumla, Alimuddin","Locatelli, Franco","Ippolito, Giuseppe","Kroemer, Guido","32292881"],"abstract":["Coronaviruses (CoVs) are a large family of enveloped, positive-strand RNA viruses. Four human CoVs (HCoVs), the non-severe acute respiratory syndrome (SARS)-like HCoVs (namely HCoV 229E, NL63, OC43, and HKU1), are globally endemic and account for a substantial fraction of upper respiratory tract infections. Non-SARS-like CoV can occasionally produce severe diseases in frail subjects but do not cause any major (fatal) epidemics. In contrast, SARS like CoVs (namely SARS-CoV and Middle-East respiratory syndrome coronavirus, MERS-CoV) can cause intense short-lived fatal outbreaks. The current epidemic caused by the highly contagious SARS-CoV-2 and its rapid spread globally is of major concern. There is scanty knowledge on the actual pandemic potential of this new SARS-like virus. It might be speculated that SARS-CoV-2 epidemic is grossly underdiagnosed and that the infection is silently spreading across the globe with two consequences: (i) clusters of severe infections among frail subjects could haphazardly occur linked to unrecognized index cases; (ii) the current epidemic could naturally fall into a low-level endemic phase when a significant number of subjects will have developed immunity. Understanding the role of paucisymptomatic subjects and stratifying patients according to the risk of developing severe clinical presentations is pivotal for implementing reasonable measures to contain the infection and to reduce its mortality. Whilst the future evolution of this epidemic remains unpredictable, classic public health strategies must follow rational patterns. The emergence of yet another global epidemic underscores the permanent challenges that infectious diseases pose and underscores the need for global cooperation and preparedness, even during inter-epidemic periods."],"journal":"Cell Stress","authors":["Raoult, Didier","Zumla, Alimuddin","Locatelli, Franco","Ippolito, Giuseppe","Kroemer, Guido"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292881","week":"202016|Apr 13 - Apr 19","doi":"10.15698/cst2020.04.216","keywords":["COVID-19","Coronavirus","MERS-CoV","SARS-CoV","epidemiology","immunology","sARS-CoV-2"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1664266295738105857,"score":268.9185},{"pmid":32246136,"title":"Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan.","text":["Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan.","BACKGROUND: As part of the Household Influenza Vaccine Evaluation (HIVE) study, acute respiratory infections (ARI) have been identified in children and adults over 8 years. METHODS: Annually, 890 to 1441 individuals were followed and contacted weekly to report ARIs. Specimens collected during illness were tested for human coronaviruses (HCoV) types OC43, 229E, HKU1, and NL63. RESULTS: In total, 993 HCoV infections were identified over 8 years, with OC43 most commonly seen and 229E the least. HCoVs were detected in a limited time period, between December and April/May, and peaked in January/February. Highest infection frequency was in children <5 years (18 per 100 person-years), with little variation in older age groups (range: 7 to 11 per 100 person-years). Overall, 9% of adult cases and 20% of cases in children were associated with medical consultation. Of the 993 infections, 260 were acquired from an infected household contact. The serial interval between index and household-acquired cases ranged from 3.2 to 3.6 days and the secondary infection risk ranged from 7.2% to 12.6% by type. CONCLUSIONS: Coronaviruses are sharply seasonal. They appear, based on serial interval and secondary infection risk, to have similar transmission potential to influenza A(H3N2) in the same population.","J Infect Dis","Monto, Arnold S","DeJonge, Peter","Callear, Amy P","Bazzi, Latifa A","Capriola, Skylar","Malosh, Ryan E","Martin, Emily T","Petrie, Joshua G","32246136"],"abstract":["BACKGROUND: As part of the Household Influenza Vaccine Evaluation (HIVE) study, acute respiratory infections (ARI) have been identified in children and adults over 8 years. METHODS: Annually, 890 to 1441 individuals were followed and contacted weekly to report ARIs. Specimens collected during illness were tested for human coronaviruses (HCoV) types OC43, 229E, HKU1, and NL63. RESULTS: In total, 993 HCoV infections were identified over 8 years, with OC43 most commonly seen and 229E the least. HCoVs were detected in a limited time period, between December and April/May, and peaked in January/February. Highest infection frequency was in children <5 years (18 per 100 person-years), with little variation in older age groups (range: 7 to 11 per 100 person-years). Overall, 9% of adult cases and 20% of cases in children were associated with medical consultation. Of the 993 infections, 260 were acquired from an infected household contact. The serial interval between index and household-acquired cases ranged from 3.2 to 3.6 days and the secondary infection risk ranged from 7.2% to 12.6% by type. CONCLUSIONS: Coronaviruses are sharply seasonal. They appear, based on serial interval and secondary infection risk, to have similar transmission potential to influenza A(H3N2) in the same population."],"journal":"J Infect Dis","authors":["Monto, Arnold S","DeJonge, Peter","Callear, Amy P","Bazzi, Latifa A","Capriola, Skylar","Malosh, Ryan E","Martin, Emily T","Petrie, Joshua G"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32246136","week":"202014|Mar 30 - Apr 05","doi":"10.1093/infdis/jiaa161","source":"PubMed","locations":["Michigan"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Transmission"],"weight":1,"_version_":1663352136158674944,"score":237.94397},{"pmid":32098422,"pmcid":"PMC7077191","title":"Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.","text":["Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV.","After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections. Recently, a new emerged HCoV isolated from the respiratory epithelium of unexplained pneumonia patients in the Wuhan seafood market caused a major disease outbreak and has been named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes acute lung symptoms, leading to a condition that has been named as \"coronavirus disease 2019\" (COVID-19). The emergence of SARS-CoV-2 and of SARS-CoV caused widespread fear and concern and has threatened global health security. There are some similarities and differences in the epidemiology and clinical features between these two viruses and diseases that are caused by these viruses. The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms.","Viruses","Xu, Jiabao","Zhao, Shizhe","Teng, Tieshan","Abdalla, Abualgasim Elgaili","Zhu, Wan","Xie, Longxiang","Wang, Yunlong","Guo, Xiangqian","32098422"],"abstract":["After the outbreak of the severe acute respiratory syndrome (SARS) in the world in 2003, human coronaviruses (HCoVs) have been reported as pathogens that cause severe symptoms in respiratory tract infections. Recently, a new emerged HCoV isolated from the respiratory epithelium of unexplained pneumonia patients in the Wuhan seafood market caused a major disease outbreak and has been named the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus causes acute lung symptoms, leading to a condition that has been named as \"coronavirus disease 2019\" (COVID-19). The emergence of SARS-CoV-2 and of SARS-CoV caused widespread fear and concern and has threatened global health security. There are some similarities and differences in the epidemiology and clinical features between these two viruses and diseases that are caused by these viruses. The goal of this work is to systematically review and compare between SARS-CoV and SARS-CoV-2 in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms."],"journal":"Viruses","authors":["Xu, Jiabao","Zhao, Shizhe","Teng, Tieshan","Abdalla, Abualgasim Elgaili","Zhu, Wan","Xie, Longxiang","Wang, Yunlong","Guo, Xiangqian"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32098422","week":"20209|Feb 24 - Mar 01","doi":"10.3390/v12020244","keywords":["*SARS-CoV","*SARS-CoV-2","*clinical manifestations","*coronaviruses","*genomic comparison","*pathogenic mechanism","*proteomic comparison"],"source":"PubMed","locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis","Mechanism"],"weight":1,"_version_":1663352134478856192,"score":214.93965}]}